Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Cash from Financing Activities (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Cash from Financing Activities for 16 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Financing Activities rose 191.57% year-over-year to $6.7 million, compared with a TTM value of $8.1 million through Sep 2025, up 112.45%, and an annual FY2024 reading of $7.3 million, down 35.21% over the prior year.
  • Cash from Financing Activities was $6.7 million for Q3 2025 at Rockwell Medical, up from -$650000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $26.8 million in Q2 2022 and bottomed at -$6.0 million in Q4 2022.
  • Average Cash from Financing Activities over 5 years is $2.1 million, with a median of -$339500.0 recorded in 2021.
  • The sharpest move saw Cash from Financing Activities crashed 162300.0% in 2021, then soared 447150.0% in 2022.
  • Year by year, Cash from Financing Activities stood at -$1.6 million in 2021, then plummeted by 268.47% to -$6.0 million in 2022, then skyrocketed by 87.6% to -$742000.0 in 2023, then soared by 476.28% to $2.8 million in 2024, then skyrocketed by 141.55% to $6.7 million in 2025.
  • Business Quant data shows Cash from Financing Activities for RMTI at $6.7 million in Q3 2025, -$650000.0 in Q2 2025, and -$783000.0 in Q1 2025.